MCA logo
MCA logo



Not just weight loss – Semaglutide and Cardiovascular Benefits

Not just weight loss – Semaglutide and Cardiovascular Benefits
With the emergence and increasing popularity of glucagon-like peptide 1 (GLP-1) agonists for the treatment of obesity in recent years, it might be worth investigating if these agents are able to reduce the cardiovascular risks associated with overweight and obesity, especially since they have been shown to reduce risk of major adverse cardiovascular events in patients with type 2 diabetes who are at high cardiovascular risk.

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

dengue philippines
Nationwide Dengue Cases Drop Significantly in Early January in PH

Health authorities have issued a cautionary note, acknowledging that these figures may fluctuate due to delayed consultations and reporting. It’s noteworthy that while most regions experienced a decline in dengue cases, Caraga and Soccsksargen regions witnessed an increase, reporting 846 and 645 cases, respectively, raising localised concerns.

Read More »